Ticker Details
Phathom Pharmaceuticals, Inc.
IPO Date:	October 21, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$717.59M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.64 | 3.81%
Avg Daily Range (30 D):	$0.41 | 3.91%
Avg Daily Range (90 D):	$0.37 | 3.34%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	1.33M
Avg Daily Volume (90 D):	1.15M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	81
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	1,121
Avg Institutional Trade:	$1.44M
Avg Institutional Trade (30 D):	$1.23M
Avg Institutional Trade (90 D):	$1.2M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.41M
Avg Closing Trade (30 D):	$1.48M
Avg Closing Trade (90 D):	$1.42M
Avg Closing Volume:	108.21K

News

May 1, 2026 @ 12:00 PM Phathom Pharmaceuticals to Highlight VOQUEZNA® ... Source: Phathom Pharmaceuticals, Inc.

Apr 13, 2026 @ 5:00 PM Eosinophilic Esophagitis Market in the US to Grow ... Source: Delveinsight

Jan 8, 2026 @ 1:41 PM Stock Market Today: S&P 500, Dow Jones, Nasdaq 100... Source: Rishabh Mishra

Jan 8, 2026 @ 3:33 AM Phathom Pharmaceuticals Announces Pricing of $130 ... Source: Na

Oct 23, 2025 @ 12:00 PM Phathom Pharmaceuticals to Highlight VOQUEZNA® ... Source: Phathom Pharmaceuticals

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.26	$-.21	$-.37
Diluted EPS	$-1.26	$-.21	$-.37
Revenue	$239.66M	$74.27M	$58.3M
Gross Profit	$198.73M	$59.18M	$46.31M
Net Income / Loss	$-99.07M	$-17.58M	$-30.37M
Operating Income / Loss	$-40.64M	$-3.97M	$-15.48M
Cost of Revenue	$40.93M	$15.1M	$12M
Net Cash Flow	$32.91M
PE Ratio